Amyloidosis occurs when the body produces abnormal proteins that bind together to form a substance called amyloid. Amyloids can deposit in any tissue or organ, including the heart, kidneys, liver and ...

I went into amyloidosis research in 1999 as a very naïve nephrologist who wanted to do clinical-based research in multisystem ...

Cardiac amyloidosis is underrecognized in patients with heart failure; however, recent improvements in the understanding of this disease have led to developments in diagnosis and treatment. Cardiac ...

Please provide your email address to receive an email when new articles are posted on . Many patients with amyloidosis take years to be diagnosed. New ASH guidelines make 12 recommendations to improve ...

Transthyretin amyloidosis (ATTR) prognosis can vary based on several factors, including the type you have, how early you were diagnosed, whether you have heart failure symptoms, and whether you have ...

The new understanding of molecular events that drive the various forms of amyloidosis has led to the expansion of therapeutic options to prevent end-stage disease or even offer a cure, which has added ...

AL (immunoglobulin light chain) amyloidosis is a rare disease that often results in progressive organ dysfunction, organ failure and eventual death. Clonal plasma cells in the bone marrow secrete free ...

AL (immunoglobulin light chain) amyloidosis is a rare disease that often results in progressive organ dysfunction, organ failure and eventual death. Clonal plasma cells in the bone marrow secrete free ...

Healio spoke with Joban Vaishnav, MD, director of the Johns Hopkins Comprehensive Amyloidosis Center, about the process of diagnosing amyloidosis, the importance of multidisciplinary care in patients ...

Amyloidosis denotes a heterogeneous group of protein misfolding disorders characterised by the extracellular deposition of insoluble amyloid fibrils in multiple organs and tissues, resulting in ...

Transthyretin-mediated (ATTR) amyloidosis is a multisystem disease caused by the abnormal deposition of misfolded transthyretin protein as amyloid fibrils in various tissues. ATTR amyloidosis presents ...

Bayer (BAYZF) said an experimental imaging agent accurately identified cardiac amyloidosis in a Phase 3 study, producing sensitivity of 94% and specificity of 86% based on agreement among independent ...